Pragmatic Clinical Trial Assessing Response to Neoadjuvant Docetaxel and Trastuzumab in Nigerian Women With Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer (ARETTA)
2026JCO Global OncologyJournalOpen access
10.1200/go-25-00287Full text0 citations